Spruce Biosciences (SPRB) Treasury Shares (2019 - 2020)
Spruce Biosciences (SPRB) posted quarterly Treasury Shares of $73.3 million for Q3 2020, up 161.9% year-over-year from $28.0 million in Q4 2019, and up 100.0% quarter-over-quarter from $36.7 million in Q2 2020.
Spruce Biosciences (SPRB) Treasury Shares (2019 - 2020) Analysis & Trends
Spruce Biosciences (SPRB) has reported Treasury Shares for 2 consecutive years, with $73.3 million the latest figure, recorded in Q3 2020.
- In Q3 2020, Treasury Shares rose 161.9% year-over-year to $73.3 million; the TTM figure through Sep 2020 stood at $73.3 million (up 161.9% YoY), while the FY2019 annual figure was $28.0 million, changed N/A from the prior year.
- Treasury Shares advanced to $73.3 million in Q3 2020 per SPRB's latest filing, from $36.7 million in the prior quarter.
- Across five years, Treasury Shares topped out at $73.3 million in Q3 2020 and bottomed at $28.0 million in Q3 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.95 Bn | 132.10 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 86.71 Bn | 78.72 Bn | 3.93 Bn | 36.40 Mn |
| 3 | Argenx Se | 65.71 Bn | 60.52 Bn | 1.37 Bn | - |
| 4 | Moderna | 60.45 Bn | 55.31 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 42.24 Bn | 37.14 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.80 Bn | 28.49 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.64 Bn | 10.25 Bn | 668.28 Mn | 8.96 Mn |
| 8 | Insmed | 27.61 Bn | 26.45 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.26 Bn | 26.42 Bn | - | 2.72 Mn |
| 10 | Spruce Biosciences | 125.93 Mn | 125.93 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2020 | 73.33 Mn |
| Sep 30, 2020 | 73.33 Mn |
| Jun 30, 2020 | 36.67 Mn |
| Jun 30, 2020 | 36.67 Mn |
| Mar 31, 2020 | 36.67 Mn |
| Mar 31, 2020 | 36.67 Mn |
| Dec 31, 2019 | 28.00 Mn |
| Dec 31, 2019 | 28.00 Mn |
| Sep 30, 2019 | 28.00 Mn |
| Sep 30, 2019 | 28.00 Mn |